Manufacturing of Cytotoxic and Non-Cytotoxic Drugs in a Multiproduct Facility

March 10, 2019

When different drug products are produced in shared facilities, the potential for cross-contamination is always a concern that needs to be addressed.

Spotlight

Novel Laboratories, Inc

Founded in December of 2006 by industry veteran, Dr. Veerappan Subramanian, Novel Laboratories, Inc. is a full-service pharmaceutical company that develops, manufactures, markets and distributes niche and difficult to develop new and generic technology-based drug products to the US and European markets.

OTHER WHITEPAPERS
news image

Understanding Net Pharmaceutical Expenditure Dynamics in Europe

whitePaper | April 12, 2022

The level of pharmaceutical expenditure is closely watched and often commented upon, but the composition of that expenditure and its dynamics are not as well understood.

Read More
news image

Advancements in Drug Development and Formulation

whitePaper | December 13, 2022

A recent e-symposium presented insights into the latest research and innovative solutions to help shorten timeto-market, reduce development costs, increase yield, and assure quality and pharmacopoeia compliance throughout the drug development process.

Read More
news image

Asia Pacific – Clinical trial landscape

whitePaper | November 8, 2022

The Asia-Pacific region has emerged as a clinical trial hub due to the ease of regulatory compliance, low trial costs, rising patient population, and the availability of top clinical institutions.

Read More
news image

Pharma R&D Annual Review 2022

whitePaper | May 5, 2022

welcome to pharmaprojects'2022 review of trends in pharmaceutical R&D for 30 year now, I've been taking an anual look at the evloution of pharma

Read More
news image

The Ultimate Guide to Digitizing Pharma Manufacturing

whitePaper | September 15, 2022

The sheer size of the pharmaceutical industry makes it important for all stakeholders to stay up to date with pharmaceutical industry trends.

Read More
news image

Patients Diagnosed with Post-COVID Conditions

whitePaper | May 18, 2022

Post-COVID conditions, also known by such terms as long COVID and post-acute sequelae of COVID-19, have become an issue of growing national concern.

Read More

Spotlight

Novel Laboratories, Inc

Founded in December of 2006 by industry veteran, Dr. Veerappan Subramanian, Novel Laboratories, Inc. is a full-service pharmaceutical company that develops, manufactures, markets and distributes niche and difficult to develop new and generic technology-based drug products to the US and European markets.

Events